4-(Methoxymethoxy)aniline - CAS 876-30-2

Catalog:	BB059231
Product Name:	4-(Methoxymethoxy)aniline
CAS:	876-30-2
Synonyms:	4-(Methoxymethoxy)benzenamine; 4-Methoxymethoxyaniline; p-(Methoxymethoxy)aniline

Technical Data

Safety and Hazards

Patents

Literatures

Computed Properties

IUPAC Name:	4-(methoxymethoxy)aniline
Description:	4-(Methoxymethoxy)aniline is a useful reagent used in the preparation of resveratrol derivatives evaluated for activation and inhibition of the TRPA1 channel.
Molecular Weight:	153.17
Molecular Formula:	C8H11NO2
Canonical SMILES:	COCOC1=CC=C(C=C1)N
InChI:	InChI=1S/C8H11NO2/c1-10-6-11-8-4-2-7(9)3-5-8/h2-5H,6,9H2,1H3
InChI Key:	PMFXZWXKPPPNSW-UHFFFAOYSA-N
References:	Nakao, S., et al. Bioorg. Med. Chem. Lett., 27, 3167 (2017).

Publication Number	Title	Priority Date
JP-2022001620-A	Polymerizable compounds, polymers, optical thin films	20200622
WO-2020196327-A1	Production method of quinolinecarboxamide derivative or production intermediate thereof	20190322
TW-202102477-A	Quinoline Carboxamide Derivatives and Manufacturing Methods of Manufacturing Intermediates	20190322
JP-2020158498-A	Method for producing quinoline carboxylic acid derivative	20190322
CN-113613730-A	Quinoline carboxamide derivative and process for producing intermediate for producing same	20190322
EP-3943159-A1	Production method of quinolinecarboxamide derivative or production intermediate thereof	20190322
CN-108699013-A	Novel spiral quinone derivative compound, preparation method and contain its pharmaceutical composition as active constituent for preventing or treating neuropathy	20160908
EP-3395804-A1	Novel spiroquinone derivative compound, production method thereof, and pharmaceutical composition for preventing or treating neurological disorders which contains same as active ingredient	20160908
EP-3395804-B1	Novel spiroquinone derivative compound, production method thereof, and pharmaceutical composition for preventing or treating neurological disorders which contains same as active ingredient	20160908
KR-101850062-B1	Novel spiroquinone compound, method for preparing the same, and pharmaceutical composition for use in preventing or treating neurological diseases containing the same as an active ingredient	20160908

PMID	Publication Date	Title	Journal
11469714	20010101	Impaired absorption and omission of insulin: a novel method of detection using the diabetes advisory system computer model	Diabetes technology & therapeutics

Related Products

Online Inquiry

Name:

* Phone:

* Service & Products of Interested:

Project Description:

* Quantity:

* Email:

* Verification Code:

Customer Support

If the product you need is not in our catalog, please contact us in time to submit your needs. You can help our website get better and better. Why not submit the request today?

Submit Requirement

Customer Centered

Global Delivery

Warehouses in multiple cities to ensure fast delivery

Quality Assurance

Strict process parameter control to ensure product quality

Large Stock

> 20,000 building blocks and intermediates from stock

Process Scale-up

Process scale-up from lab to industrial scale

Flexible Batch Size

Flexible batch size for diverse industrial demands

Related Functional Groups

Other Building Blocks

[88563-82-0]
1- (1- Bromoethyl) - 3- methylbenzene
[128076-60-8]
1- (2- Aminophenyl) - 2- iodoethanone
[29278-68-0]
1,4-Butanediol Terephthalate Dibenzyl Ester
[951987-97-6]
N-((4-Oxo-1-phenyl-4,7-dihydro-1H-pyrazolo[3,4-d]pyrimidin-6-yl)methyl)acetamide
[1365727-07-6]
6-Methyldi(ondansetron-3-de(1,2-dimethyl-1H-imidazole))
[1242933-88-5]
Fmoc-Lys(5-FAM)-OH

Customers Also Viewed

[163702-08-7]
Methyl perfluoroisobutyl ether
[1866059-82-6]
1,1,2,2-Tetrafluoro-3-methylsulfonylpropane
[87117-22-4]
1,4-Bis(2-ethylhexyl)benzene
[169689-05-8]
1S,2S-DHAC-Phenyl Trost Ligand
[132182-92-4]
Pentane, 1,1,1,2,2,3,4,5,5,5-decafluoro-3-methoxy-4-(trifluoromethyl)-
[35153-16-3]
(Z)-10-Tetradecenyl Acetate

INDUSTRY LEADERS TRUST OUR PRODUCTS

Phone

US & Canada (Toll free):

UK:

International:

E-mail & Fax

E-mail:

Fax:

Address

USA:

UK:

Our Products

Inquiry Basket

Loading ......

Delete selected Go to checkout

GHS Hazard Statement:	H302 (100%): Harmful if swallowed [Warning Acute toxicity, oral]
Precautionary Statement:	P261, P264, P264+P265, P270, P271, P280, P301+P317, P302+P352, P304+P340, P305+P351+P338, P317, P319, P321, P330, P332+P317, P337+P317, P362+P364, P403+P233, P405, and P501
Signal Word:	Warning

Complexity:	100
Compound Is Canonicalized:	Yes
Covalently-Bonded Unit Count:	1
Defined Atom Stereocenter Count:	0
Defined Bond Stereocenter Count:	0
Exact Mass:	153.078978594
Formal Charge:	0
Heavy Atom Count:	11
Hydrogen Bond Acceptor Count:	3
Hydrogen Bond Donor Count:	1
Isotope Atom Count:	0
Monoisotopic Mass:	153.078978594
Rotatable Bond Count:	3
Topological Polar Surface Area:	44.5Å²
Undefined Atom Stereocenter Count:	0
Undefined Bond Stereocenter Count:	0
XLogP3:	0.8